According to the recent study the global subcutaneous drug delivery device market is projected to reach an estimated $50 billion by 2030 from $25 billion in 2023 at a CAGR of 11% from 2023 to 2030. Growth in this market is primarily driven by increasing number of cases for diabetes and cardiovascular diseases (CVD) and expanding use of these delivery systems for various biomedical drug advances and immunisation campaign.
A more than 150–page
report is developed to understand trends, opportunities and forecast in
subcutaneous drug delivery device market by product (prefilled syringes, pen
injectors, auto-injectors, wearable injectors, and needle-free injectors),
distribution channel (hospital pharmacies, retail pharmacies, and online
pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of
the World)
Lucintel forecasts that
prefilled syringes will remain the largest segment over the forecast period due
to its expanding usage because of its easy-to-use features, easily
availability, cost effectiveness, and high societal acceptance.
Retail pharmacy is
expected to remain the largest segment due to patients’ growing preference for
physical pharmacies owing to quick availability of medication and expanding
number of retail pharmacies.
Download sample by clicking on
subcutaneous drug delivery device
market
North America will
remain the largest region due to presence of advanced healthcare
infrastructure, introduction of needle-free subcutaneous drug delivery device,
and growing number of chronic disease cases in the region.
Gerresheimer, Medtronic,
Ypsomed, Elcam Medical Group, and Novo Nordisk are among the major subcutaneous
drug delivery device market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Natural Angelica Extract Ligustilide Market
Consumer to Consumer E-Commerce Market
Automatic Chain Lubrication System Market
No comments:
Post a Comment